D3 Antibody

Datasheet

Code	CSB-PA726105XA01OFG
Size	Enquire
Have Questions?	Leave a Message or Start an on-line Chat

Product Details
Related Products
Customer Reviews and Q&A
Target Background

Product Details

Full Product Name

Rabbit anti-Oryza sativa subsp. japonica (Rice) D3 Polyclonal antibody

Uniprot No.

Q5VMP0

Target Names

Alternative Names

D3 antibody; Os06g0154200 antibody; LOC_Os06g06050 antibody; OSJNBa0085L11.6-1F-box/LRR-repeat MAX2 homolog antibody; F-box and leucine-rich repeat MAX2 homolog antibody; Protein DWARF 3 antibody

Raised in

Rabbit

Species Reactivity

Oryza sativa subsp. japonica (Rice)

Immunogen

Recombinant Oryza sativa subsp. japonica (Rice) D3 protein

Immunogen Species

Oryza sativa subsp. japonica (Rice)

Conjugate

Non-conjugated

Clonality

Polyclonal

Isotype

IgG

Purification Method

Antigen Affinity Purified

Concentration

It differs from different batches. Please contact us to confirm it.

Buffer

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Form

Liquid

Tested Applications

ELISA, WB (ensure identification of antigen)

Protocols

ELISA Protocol

Troubleshooting and FAQs

Antibody FAQs

Storage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Value-added Deliverables

① 200ug * antigen (positive control);
② 1ml * Pre-immune serum (negative control);

Quality Guarantee

① Antibody purity can be guaranteed above 90% by SDS-PAGE detection;
② ELISA titer can be guaranteed 1: 64,000;
③ WB validation with antigen can be guaranteed positive;

Lead Time

Made-to-order (14-16 weeks)

Customer Reviews and Q&A

■ Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function

Involved in strigolactone (SL) signaling. Required for responses to SLs and the establishment of arbuscular mycorrhiza symbiosis in rice. Strigolactone-dependent association of D3 with D14 and D53 (a repressor of SL signaling) triggers D53 ubiquitination and degradation. Controls tillering by suppressing axillary bud activity. Tiller is a specialized grain-bearing branch that is formed on the unelongated basal internode and grows independently of the mother stem (culm) by means of its own adventitious roots.

Subcellular Location

Nucleus.

Tissue Specificity

Expressed in leaves. Expressed in roots, culms, leaf blades, leaf sheaths, shoot bases and panicles.

Database Links

KEGG: osa:9272469

STRING: 39947.LOC_Os06g06050.1

UniGene: Os.18946

Promotions

Transmembrane Protein Questionnaire with Gifts

Email: [email protected]
Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

GPC3: The Next-Promising Target in Cancer Immunotherapy Claudin 18.2, is a 'Dark Horse' in Anti-tumour Therapy? Multiple Myeloma, One of High-Risk Factors for COVID-19 Two Types of Macrophages: M1 and M2 Macrophages TNFR1: A Multifaceted Molecule in Cancer, Another Promising Therapeutic Target for COVID-19 CCR8: a Specific Marker on Tregs Cells, the Next Promising Candidate for Antitumor Drugs! Lysosomal Enzymes and Lysosomal Storage Disorders (LSDs) DLL3: A New Molecular Target in Cancer DT3C, a Powerful Tool for ADC Drug Internalization In Vitro Proteolysis Targeting Chimera (PROTAC): A CLDN6: A "New Favorite" in Targeted Cancer Therapy after CLDN 18.2! TPBG/5T4: the Oncofetal Protein, an Appealing Target for ADC or Vaccine Therapeutics in Tumors! GPRC5D: Newly Efficient GPRC5D CAR-T or Bispecific Antibody Therapy to Fight Multiple Myeloma (MM) Dual Role of TNFRSF14 in Immunology CD31- A Complex Function Molecule Surface Markers That Help You Identify Lymphocytes CD73, What a Powerful Therapy Target in Tumor Immune CAR-T Cell Therapy- An Useful Treatment To Cancer CLDN4: A Potential Prognostic Indicator and Therapeutic Target in Tumors！ CD19-The Most Popular Target with CAR T-Cell Therapy Categories over 10000! --Rare diseases that are no longer Differentiation of Th17 Cells Microglial Markers: Insights into Microglial Activation and Function Homeobox Transcription Factor- NANOG Costimulatory/Coinhibitory: Is B7-H3 An Enemy or A Friend? The Overview of Fc Receptors- Classification, Related Signaling Pathways and Application DSG2: a Vital Member of Desmosomal Cadherin Family, an Exciting New Target for Cardiomyopathy, Adenovirus, and Tumors! MYL9: a New Member of Myosin Motors, a Key Driver of Cancer Cell Dynamic Regulation? New Mechanism, NRP1 Enhances the Ability of SARS-CoV-2 Infection Surface Markers of Mesenchymal Stem Cells Bladder Cancer: Insights into Molecular Biology,Signaling Pathways, and Biomarkers Stem Cell-What a Miraculous Resource in Human Body CEACAM5: A Promising Member of CEACAM Family, A Potential Target for ADC Drug Research! The Application of IHC in Pathological Diagnosis CD46, A Complement Regulator ACVRL1 (Alk1): a Member of the TGF-β Receptor Family, a Novel Target for Anti-Angiogenic Drug Research! What Factors Could Affect ELISA Results? CD47, A New Target for Tumor Immune Hematopoietic Stem Cell Surface Marker CD20 Monoclonal Antibodies Drugs: There is an Explosion of New mAbs Against CD20! Tumor Necrosis Factor Receptor Superfamily and Apoptosis VSIG4: a Prominent B7 Family Costimulatory Molecule or Complement Receptor in Cancers and Inflammatory Diseases! Monoclonal Antibody Drugs Overview SLC39A6/ZIP6: a Key Member of Zinc Transporters, a Novel Targeting Antigen of ADC! TMEFF2: a Tumor-Specific Methylated Biomarker, a Novel Target in Multiple Cancers The Overview of Hippo Signaling Pathway How do Th1 and Th2 Cells Differentiate? Unraveling the Dynamic World of Histone Modifications: Implications in Gene Regulation and Disease Pathogenesis Identify Treg Cells. You Can Do This. The Multifunctional Enzyme CD38: A Target for Immunotherapeutic Approaches in Cancer What Are the Effects of Abnormalities in the ALK Gene Mesothelin: A Rising Star of Cancer Immunotherapy CD70 (CD27L/TNFSF7): a TNF Receptor Member, a “Star” Target for Clinical Research in Systemic Lupus Erythematosus (SLE), Arthritis, and Tumors! PD-1-- An Important Immune Checkpoint Tetraspanin CD81: a Key Receptor for Hepatitis C Virus (HCV), an Established Exosome Marker, a Promising Target for Antiviral or Antitumor Research! CRTAM: Class I Restricted T cell-associated Molecule, an Intriguing New Member of the Ig-SF Family! Does TNF Superfamily Inhibit Cancer or Promote Its Development? TMPRSS2, an Activator for SARS-CoV-2 Invasion CD Antigens - From Leucocytes Surface Markers to Diagnostic Markers for Cancer TM4SF1: a Member of the Transmembrane-4-Superfamily (L6), a New Vascular Therapeutic Target? Surface Markers of Natural Killer Cells LY6G6D (LY6-G): A New Member of Lymphocyte Antigen-6 Family Holds Big Opportunities in Bispecific Antibody for CRC Treatment! Mucin-17/MUC17: An Unexpected Target for Tumor Immune Therapy, Notably Gastric Cancer! The Overview of Chemokine IL-17A: A Major Cytokine of the IL-17 Family, a Key Inflammation Target in Skin Diseases, or Inflammation-Associated Cancers! The Overview of Colony Stimulating Factors Do You Really Know Neurons and Glia Cells in Nerve System? CD69: a Classical Early Marker of Lymphocyte Activation, a Pivotal Regulator of Hematologic Diseases and Autoimmune Disorders! Cadherin-17 (CDH17): A Viable Target in Bispecific Antibodies or CAR-T Therapy to Fight Many Gastrointestinal Cancers! The Memory thief - Alzheimer's disease The Overview of Growth Factor Tumor Necrosis Factor (TNF) The Overview of Interferon A Group of Promising Proteins - Cell Cycle Markers The Overview of Organelles CDCP1: A Key Mediator for Cell Signaling in Cancers, an Emerging Target for Anti-Tumor Drugs! The overview of Wnt signaling pathway The overview of TGF-β signaling pathway Double-Edged Sword: TGF-β Do You Really Know TGF-β Superfamily? CCR9: A Member of the Chemokine Receptor Family, an Emerging Target for Numerous Tumor Researches! CEACAM6: a Potent CEA Family Molecule, a New Tumor Marker or Anti-Cancer Target! IL2RA (CD25): A Specific Marker of Tregs Functions as Both Immune Modulators and Targeted Agents in Various Diseases! Bispecific Antibody Overview: From Definition to Application PROM1 (CD133): A New Cell Surface Marker of Cancer Stem Cells (CSCs), A More Significant Target for Immunotherapy! BDCA2/CLEC4C: a Novel Plasma Cell-Like Dendritic Cell (pDC) Marker and Potent Inhibitor of IFN-I that Blocks SLE Development! ENPP3 (CD203c): An Extracellular Enzyme, a Regulator for Nucleotide and Energy, an Indicator for Allergies, an Effective Target for RCC Therapy! ROR1, an Emerging Target for Tumor Immunotherapy GUCY2C: a Novel Target in Tumor Immunotherapy, Specially in Colorectal Cancer CAR T Therapy! SSTR2: A Prominent Target in SSTR Family, Offers a More Precise Therapy in Neuroendocrine Tumors (NET) CADM1: an Immunoglobulin Superfamily Molecule, a New Tumor Suppressor Gene! Oncostatin M (OSM): A Member of IL-6 Cytokine Family, An Underestimated Player in Future Targeted Therapies? MAGEA4: a Member of the Melanoma-Associated Antigen (MAGE) Family, a Popular Target for Tumor-Specific Immune Research! Antibody FAQs What Is an Antibody? How to Choose an Antibody for Scientific Research? The difference between primary antibody and secondary antibod The Meaning of Irregular Antibody Screening Tag Antibodies, Your Good Partner in Protein Research How to Choose the Loading Control Antibodies?

Call us

301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)

[email protected]

Address

7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA

Join us with

Subscribe newsletter

Leave a message

Message

Product >> Product Name：
Product >> Code：
Name： *
Email： *
Company/Organization：
Phone：
Since emails may get flagged by spam filters occasionally, we recommend leaving your phone number as a precaution. Your information is safe with us.
Question/Comment： *
Your Region： *
I'd like to receive email newsletters from Cusabio

Yes

No
How do you know CUSABIO?

Email

Distributor

Search engine

Advertisement

Others
CAPTCHA verification：

D3 Antibody

Product Details

Related Products

Customer Reviews and Q&A

Target Background